With the exception of Humira, the drugs you cited have been commercial dogs. Although a drug can get FDA approval in RA by showing superiority to placebo, commercial uptake is greatly enhanced if the sponsor can show at least non-inferiority relative to a big-selling comparator.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”